Jardy Met 12.5/850mg Tablets are a fixed-dose combination containing Empagliflozin 12.5mg (an SGLT2 inhibitor) and Metformin 850mg (a biguanide) for the management of type 2 diabetes mellitus. Empagliflozin works by inhibiting sodium-glucose cotransporter-2 in the kidneys, increasing urinary glucose excretion, while Metformin lowers hepatic glucose output and improves peripheral insulin sensitivity.

Together these two agents provide complementary glycaemic control and are prescribed when a single anti-diabetic drug is insufficient. The higher Empagliflozin dose (12.5mg) offers enhanced glucose lowering compared to the 5/1000mg formulation, making it suitable for patients requiring tighter blood sugar management. Empagliflozin also provides cardiovascular and kidney-protective benefits in high-risk patients.

Take Jardy Met 12.5/850mg as prescribed — usually once or twice daily with meals. Swallow tablets whole; do not crush or chew. Regular monitoring of blood glucose, HbA1c, renal function, and blood pressure is recommended throughout treatment.

Common side effects include nausea, diarrhoea, or mild stomach discomfort on initiation. Serious but rare side effects include lactic acidosis and urinary or genital infections. A valid prescription is required — send it via WhatsApp: +92-320-5999650 or email: sales@derma.pk. Derma.pk delivers Jardy Met tablets across Pakistan including Lahore, Karachi, and Islamabad.